RT Journal Article SR Electronic T1 Determinants of Timely Malaria Treatment among Under-Five Children Attending Public Health Facilities in Kisumu East Sub-County, Kenya: A Health Facility-Based Cross-Sectional Study JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.07.22.24310789 DO 10.1101/2024.07.22.24310789 A1 Ochieng, Geofrey A1 Sampa, Mutale A1 Maritim, Patricia A1 Silumbwe, Adam A1 Zulu, Joseph M A1 Kato, Joseph A1 Jacobs, Choolwe YR 2024 UL http://medrxiv.org/content/early/2024/07/22/2024.07.22.24310789.abstract AB Evidence shows that most child malaria deaths occur at home shortly after symptom onset, highlighting the need for timely treatment. This study aimed to assess the determinants of timely malaria treatment among under-five children who receive care at public health facilities in Kisumu East sub-county, Kenya.A health facility-based cross-sectional study was conducted in Kisumu East sub-county, Kenya, between 5th April and 26th May 2023. The study employed a two-stage stratified-cluster sampling method, first selecting hospitals and then using systematic sampling to select caregivers. Data collection was done electronically using structured questionnaires. Associations at bivariable level were assessed using either the Chi-square or Fisher’s exact test based on assumptions. Multiple logistic regression with robust standard errors was applied at a 5% significance level to establish determinants of timely malaria treatment among under-five children. STATA version 16 (College Station, Texas 77845 USA) was used for all analyses.The sample included a total of 434 caregivers of under-five children. The study revealed that caregivers’ ability to recognize malaria symptoms was associated with higher odds of seeking timely malaria treatment for their children (AOR=2.92; 95% CI=1.36-6.25; p=0.006). Additionally, having health insurance cover was associated with higher odds of timely treatment (AOR=2.12; 95% CI=1.25-3.59; p=0.005). Those who visited herbalists before seeking care were less likely to seek timely treatment (AOR=0.13; 95% CI=0.05-0.34; p<0.0001). Fear of drugs’ side effects reduced the odds of timely treatment (AOR=0.50; 95% CI=0.29-0.87; p=0.013).Timely malaria treatment was linked to the ability to tell symptoms and having health insurance, while delayed malaria treatment was related to herbalist visits and fear of malaria, among others. There is need for relevant stakeholders to implement strategies that address misconceptions about drug side effects, offer affordable insurance, integrate the informal health sector, and educate caregivers about under-five malaria symptoms in order to promote timely malaria treatment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere are no financial grants to be disclosedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:university of Zambia Biomedical Research Ethics Committee (UNZABREC), reference number 3446-2022 Maseno University Ethics Review Committee (MUERC) with a reference number MSU/DRPI/MUSERC/01189/23 Research permit was also obtained from National Commission for Science, Technology and Innovation (NACOSTI) with a licence number NACOSTI/P/23/24218I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableData will be made available upon requestKIMSKenya Malaria Indicator SurveyKNBSKenya National Bureau of StatisticsRDTRapid Diagnostic TestMOHMinistry of Health KenyaWHOWorld Health OrganisationSDGsSustainable Development GoalsAORAdjusted Odds RatioPMIPresident Malaria Initiative